Dosimetric Perturbation and Bragg Peak Degradation Analysis Due to Medical Fiducial Marker Material Variations in Proton Beam Therapy

Authors

  • Meutya Mahadewi Indonesia Defense University, Indonesia
  • Sovian Aritonang Indonesia Defense University, Indonesia
  • Hotma Renta R. Siringoringo Indonesia Defense University, Indonesia
  • Radha Aura P Indonesia Defense University, Indonesia
  • Ravelina Medhy Indonesia Defense University, Indonesia
  • Aulia Putri Ariendi Indonesia Defense University, Indonesia
  • Luthfiah Maharani Indonesia Defense University, Indonesia

DOI:

https://doi.org/10.59585/ijhs.v4i4.2022

Keywords:

Proton Beam Therapy, Bragg Peak, Fiducial Markers, Dose Perturbation, Medical Physics

Abstract

Proton Beam Therapy (PBT) is an advanced radiotherapy modality that offers superior dosimetric advantages due to its depth-dose profile or Bragg Peak curve, which minimizes radiation exposure to healthy tissues beyond the tumor. However, the clinical accuracy of PBT is heavily influenced by the use of fiducial markers for target localization, which often induce dose perturbation and imaging artifacts due to high-Z conventional materials. This study aims to analyze and evaluate the effect of medical fiducial marker material variations on dose perturbation magnitude, Bragg Peak degradation, and image artifact levels in Proton Beam Therapy systems. The research was conducted using numerical simulation/comparative methods to examine various marker material variations. The results indicate that alternative materials such as low-Z composites and ceramic markers significantly reduce dose perturbation and range degradation compared to conventional high-Z materials while maintaining acceptable CT imaging visibility. Overall, selecting the appropriate marker material is proven crucial in maintaining dosimetric accuracy and minimizing Bragg Peak distortion in proton radiotherapy procedures.

Downloads

Download data is not yet available.

References

Ahmad, S., et al. (2018). Dosimetric impact of high-atomic-number fiducial markers in proton beam therapy. Physics in Medicine & Biology, 63(12), 125004.

Cheung, J., et al. (2021). Artifact reduction and Monte Carlo evaluation of ceramic and polymeric fiducial markers for image-guided proton therapy. International Journal of Radiation Oncology , Biology, Physics, 109(3), 812–821.

Giebeler, A., et al. (2023). Proton beam range uncertainties and secondary dose perturbations induced by metallic implants. Medical Physics, 50(4), 2341–2355.

Kim, J. Y., et al. (2020). Evaluation of dose perturbation and imaging artifacts for helical gold and alternative markers in proton therapy. Frontiers in Oncology, 10, 582104.

Reidel, K., et al. (2022). Comparative dosimetric study of low-Z versus high-Z fiducial markers in pencil beam scanning proton therapy. Journal of Applied Clinical Medical Physics, 23(8), e13655.

Downloads

Published

2026-11-17

How to Cite

Mahadewi, M., Aritonang, S., Siringoringo, H. R. R., Aura P, R., Medhy, R., Ariendi, A. P., & Maharani, L. (2026). Dosimetric Perturbation and Bragg Peak Degradation Analysis Due to Medical Fiducial Marker Material Variations in Proton Beam Therapy. International Journal of Health Sciences, 4(4), 1368–1374. https://doi.org/10.59585/ijhs.v4i4.2022